DoveBid, an online auctioneer that was due to go public this week, has pulled its $54m (€54.7m) flotation, following on from one of the the bleakest quarters ever for initial public offerings in the US.
Last week LipoScience, a medical technology company long tipped to reopen the US market, postponed its $75m offering led by Merrill Lynch. JP Morgan was leading the DoveBid IPO.